Annual Operating Profit
-$194.56 M
+$9.79 M+4.79%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual operating income is -$194.56 million, with the most recent change of +$9.79 million (+4.79%) on December 31, 2024.
- During the last 3 years, TXG annual operating profit has fallen by -$141.65 million (-267.70%).
- TXG annual operating profit is now -991.74% below its all-time high of -$17.82 million, reached on December 31, 2018.
Performance
TXG Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$49.84 M
-$8.35 M-20.14%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly operating income is -$49.84 million, with the most recent change of -$8.35 million (-20.14%) on December 31, 2024.
- Over the past year, TXG quarterly operating profit has dropped by -$8.35 million (-20.14%).
- TXG quarterly operating profit is now -4356.11% below its all-time high of $1.17 million, reached on September 30, 2018.
Performance
TXG Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$194.56 M
-$14.23 M-7.89%
December 31, 2024
Summary
- As of February 26, 2025, TXG TTM operating income is -$194.56 million, with the most recent change of -$14.23 million (-7.89%) on December 31, 2024.
- Over the past year, TXG TTM operating profit has dropped by -$14.23 million (-7.89%).
- TXG TTM operating profit is now -16714.77% below its all-time high of $1.17 million, reached on September 30, 2018.
Performance
TXG TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TXG Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | -20.1% | -7.9% |
| 3 y3 years | -267.7% | -20.1% | -7.9% |
| 5 y5 years | -569.3% | -20.1% | -7.9% |
TXG Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -267.7% | +4.8% | -214.8% | +21.3% | -267.7% | +9.0% |
| 5 y | 5-year | -569.3% | +4.8% | -2013.6% | +21.3% | -569.3% | +9.0% |
| alltime | all time | -991.7% | +4.8% | -4356.1% | +21.3% | <-9999.0% | +9.0% |
10x Genomics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$194.56 M(-4.8%) | -$49.84 M(+20.1%) | -$194.56 M(+7.9%) |
| Sep 2024 | - | -$41.48 M(-0.6%) | -$180.33 M(-6.2%) |
| Jun 2024 | - | -$41.74 M(-32.1%) | -$192.24 M(-10.1%) |
| Mar 2024 | - | -$61.50 M(+72.7%) | -$213.86 M(+4.7%) |
| Dec 2023 | -$204.35 M(+21.7%) | -$35.61 M(-33.3%) | -$204.35 M(+6.5%) |
| Sep 2023 | - | -$53.39 M(-15.7%) | -$191.84 M(+7.5%) |
| Jun 2023 | - | -$63.36 M(+21.9%) | -$178.44 M(+0.1%) |
| Mar 2023 | - | -$51.99 M(+125.1%) | -$178.20 M(+6.1%) |
| Dec 2022 | -$167.94 M(+217.4%) | -$23.10 M(-42.3%) | -$167.94 M(+4.5%) |
| Sep 2022 | - | -$40.00 M(-36.6%) | -$160.68 M(+17.7%) |
| Jun 2022 | - | -$63.12 M(+51.2%) | -$136.56 M(+61.4%) |
| Mar 2022 | - | -$41.73 M(+163.6%) | -$84.62 M(+59.9%) |
| Dec 2021 | -$52.91 M | -$15.83 M(-0.3%) | -$52.91 M(+34.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$15.88 M(+42.1%) | -$39.44 M(-17.6%) |
| Jun 2021 | - | -$11.18 M(+11.5%) | -$47.85 M(-36.8%) |
| Mar 2021 | - | -$10.03 M(+325.2%) | -$75.77 M(-11.2%) |
| Dec 2020 | -$85.32 M(+193.5%) | -$2.36 M(-90.3%) | -$85.32 M(-6.1%) |
| Sep 2020 | - | -$24.29 M(-37.9%) | -$90.90 M(+20.1%) |
| Jun 2020 | - | -$39.10 M(+99.7%) | -$75.71 M(+63.1%) |
| Mar 2020 | - | -$19.58 M(+146.7%) | -$46.41 M(+59.6%) |
| Dec 2019 | -$29.07 M(+63.1%) | -$7.94 M(-12.7%) | -$29.07 M(+14.2%) |
| Sep 2019 | - | -$9.10 M(-7.1%) | -$25.46 M(+67.6%) |
| Jun 2019 | - | -$9.79 M(+336.2%) | -$15.20 M(+181.1%) |
| Mar 2019 | - | -$2.25 M(-48.2%) | -$5.41 M(+71.0%) |
| Dec 2018 | -$17.82 M(-3.0%) | -$4.33 M(-469.9%) | -$3.16 M(-369.9%) |
| Sep 2018 | - | $1.17 M | $1.17 M |
| Dec 2017 | -$18.38 M | - | - |
FAQ
- What is 10x Genomics annual operating income?
- What is the all time high annual operating profit for 10x Genomics?
- What is 10x Genomics annual operating profit year-on-year change?
- What is 10x Genomics quarterly operating income?
- What is the all time high quarterly operating profit for 10x Genomics?
- What is 10x Genomics quarterly operating profit year-on-year change?
- What is 10x Genomics TTM operating income?
- What is the all time high TTM operating profit for 10x Genomics?
- What is 10x Genomics TTM operating profit year-on-year change?
What is 10x Genomics annual operating income?
The current annual operating profit of TXG is -$194.56 M
What is the all time high annual operating profit for 10x Genomics?
10x Genomics all-time high annual operating income is -$17.82 M
What is 10x Genomics annual operating profit year-on-year change?
Over the past year, TXG annual operating income has changed by +$9.79 M (+4.79%)
What is 10x Genomics quarterly operating income?
The current quarterly operating profit of TXG is -$49.84 M
What is the all time high quarterly operating profit for 10x Genomics?
10x Genomics all-time high quarterly operating income is $1.17 M
What is 10x Genomics quarterly operating profit year-on-year change?
Over the past year, TXG quarterly operating income has changed by -$8.35 M (-20.14%)
What is 10x Genomics TTM operating income?
The current TTM operating profit of TXG is -$194.56 M
What is the all time high TTM operating profit for 10x Genomics?
10x Genomics all-time high TTM operating income is $1.17 M
What is 10x Genomics TTM operating profit year-on-year change?
Over the past year, TXG TTM operating income has changed by -$14.23 M (-7.89%)